Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 428, 607-608 (8 April 2004) | doi:10.1038/nature02500; Published online 21 March 2004
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Fast Growth of Transformed Soybean Shoots
A method for accelerating growth of soybean shoots is desired.
- More Challenges
- Powered by:
nature jobs
Team Leader for Analytical Development
- Novo Nordisk
- Bagsværd, Denmark
Sensory Scientist
- Philip Morris International (PMI)
- Neuchatel, Switzerland
Stem cells: Lost in translation
Kenneth R. Chien1
Abstract
The potential use of stem cells as agents of repair in human disease makes them the subject of high-profile studies. But we should be wary of prematurely pushing laboratory research into clinical practice.
On the road map for 'translational medicine' — often referred to as bench-to-bedside research — stem-cell therapy is a prime destination. Stem cells are cells that have not taken on the identity of any specific cell type and are not yet committed to any dedicated function; they can divide indefinitely and may be induced to give rise to one or more specialized cell types.
- Kenneth R. Chien is at the Institute of Molecular Medicine, University of California, San Diego, La Jolla, California 92093, USA.
Email: kchien@ucsd.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Research NotesNature Biotechnology News and Views (01 May 2004)
Cardiology Solace for the broken-hearted?Nature News and Views (10 Feb 2005)
See all 6 matches for News And ViewsRESEARCH
Lengthening the G1 phase of neural progenitor cells is concurrent with an increase of symmetric neuron generating division after strokeJournal of Cerebral Blood Flow & Metabolism Original Article
Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopesNature Biotechnology Research (01 Jan 2003)
See all 27 matches for Research